Safety of a Ready to Drink Supplement

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

28 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-01-01

Study Completion Date

2016-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study will examine a Ready to Drink (RTD) supplement.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessment of a Pre-Workout Dietary Supplement

NCT02952014

Dietary Modification

COMPLETED NA

Assessment of a Pre-Workout Supplement

NCT03022604

Exercise Ergogenics

COMPLETED NA

Effects of a Pre-Workout Dietary Supplement on Training Adaptations

NCT02999581

Dietary Modification

COMPLETED NA

Influence of Caffeinated and Non-caffeinated Pre-workout Supplements on Resistance Exercise Performance

NCT04712578

Resistance Training Caffeine Dietary Supplements

COMPLETED NA

The Effect of a Caffeine Blend on Reaction Time, Mental Performance and Focus in Athletic Males

NCT03019523

Mental Fatigue

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study will examine the short-term (7 days) characteristics of ingesting a Ready to Drink (RTD) supplement immediately prior to exercise on the blood, heart rate, blood pressure and self-reported side effects.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dietary Supplements

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

DOUBLE

Participants Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

RTD

2.1 g. beta alanine, 1.3 g arginine nitrate, 200 mg caffeine, 65 mg niacin, 325 mcg folic acid, 45 mcg vitamin B12

Group Type EXPERIMENTAL

RTD

Intervention Type DIETARY_SUPPLEMENT

Ready to Drink Supplement

Placebo

dextrose and non-caloric flavoring

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type DIETARY_SUPPLEMENT

Placebo

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

RTD

Ready to Drink Supplement

Intervention Type DIETARY_SUPPLEMENT

Placebo

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants are apparently healthy and recreationally active males and females between the ages of 18 and 40

Exclusion Criteria

* Participants are under 18 years old and above 40 years old
* Participants have a history of treatment for metabolic disease (i.e., diabetes), hypertension, hypotension, thyroid disease, arrhythmias and/or cardiovascular disease
* Participants currently use any prescription medication (birth control is allowed)
* Participants are pregnant or lactating females or plan to become pregnant within the next month
* Participants have a history of smoking
* Participants drink excessively (12 drinks per week or more)
* Participants have a recent history of creatine supplementation within 8 weeks of the start of supplementation

Minimum Eligible Age

18 Years

Maximum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes